Mereo BioPharma Group PLC (MREO)
3.71
+0.03
(+0.82%)
USD |
NASDAQ |
Nov 22, 14:40
Mereo BioPharma Group Total Assets (Quarterly): 88.75M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.75M |
| June 30, 2024 | 96.13M |
| March 31, 2024 | 55.94M |
| December 31, 2023 | 66.50M |
| June 30, 2023 | 101.71M |
| December 31, 2022 | 77.41M |
| June 30, 2022 | 131.04M |
| June 30, 2022 | 131.04M |
| December 31, 2021 | 170.62M |
| June 30, 2021 | 200.57M |
| June 30, 2021 | 200.57M |
| December 31, 2020 | 85.79M |
| June 30, 2020 | 135.13M |
| June 30, 2020 | 135.13M |
| Date | Value |
|---|---|
| December 31, 2019 | 113.35M |
| June 30, 2019 | 135.78M |
| June 30, 2019 | 135.78M |
| December 31, 2018 | 85.37M |
| June 30, 2018 | 107.31M |
| June 30, 2018 | 107.31M |
| December 31, 2017 | 130.19M |
| June 30, 2017 | 116.73M |
| June 30, 2017 | 116.73M |
| December 31, 2016 | 107.05M |
| June 30, 2016 | 134.49M |
| June 30, 2016 | 134.49M |
| December 31, 2015 | 59.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
55.94M
Minimum
Mar 2024
200.57M
Maximum
Jun 2021
119.31M
Average
113.35M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| NuCana PLC | 25.38M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Bicycle Therapeutics PLC | 996.75M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.21M |
| Shareholders Equity (Quarterly) | 72.54M |